Cue Biopharma (CUE) Prepaid Assets (2017 - 2025)
Cue Biopharma (CUE) posted Prepaid Assets of $1.3 million for Q4 2025, down 57.96% sequentially from $3.1 million in Q3 2025, and up 62.61% YoY from $805000.0 in Q4 2024.
Cue Biopharma (CUE) Prepaid Assets (2017 - 2025) Analysis & Trends
Cue Biopharma has reported Prepaid Assets for 9 years, with the latest figure at $1.3 million in Q4 2025.
- Quarterly Prepaid Assets rose 62.61% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 62.61% YoY) and the FY2025 annual result came in at $1.3 million, up 62.61% from the prior year.
- Prepaid Assets retreated to $1.3 million in Q4 2025 per CUE's latest filing, from $3.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.1 million in Q3 2025 and troughed at $160000.0 in Q2 2021.
- A 5-year average of $1.7 million and a median of $1.9 million in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 1238.75% in 2022, then sank 32.31% in 2023.
- Over 5 years, Prepaid Assets stood at $954792.0 in 2021, then dropped by 11.92% to $841000.0 in 2022, then increased by 13.56% to $955000.0 in 2023, then declined by 15.71% to $805000.0 in 2024, then soared by 62.61% to $1.3 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.3 million, $3.1 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 805,000.00 |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 955,000.00 |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 841,000.00 |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 954,792.00 |
| Sep 30, 2021 | 1.85 Mn |
| Jun 30, 2021 | 160,000.00 |
| Mar 31, 2021 | 2.74 Mn |